Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein

被引:68
作者
Rhee, EJ
Lee, WY [1 ]
Kim, SY
Kim, BJ
Sung, KC
Kim, BS
Kang, JH
Oh, KW
Oh, ES
Baek, KH
Kang, MI
Woo, HY
Park, HS
Kim, SW
Lee, MH
Park, JR
机构
[1] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Sch Med, Seoul 110746, South Korea
[2] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Res Inst Med Sci, Sch Med, Seoul 110746, South Korea
[3] Hallym Univ, Dept Internal Med, Coll Med, Anyang 431070, Pyungchon, South Korea
[4] Miz Medi Hosp, Dept Internal Med, Seoul 157280, South Korea
[5] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul 137701, South Korea
[6] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Lab Med, Sch Med, Seoul 110746, South Korea
关键词
atherosclerosis; coronary artery disease; C-reactive protein (CRP); left ventricular mass index; osteoprotegerin;
D O I
10.1042/CS20040255
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
OPG (osteoprotegerin) is an inhibitor of osteoclastogenesis and recent work suggests it has a role in atherosclerosis. Therefore we measured serum OPG levels in patients with coronary artery disease, compared the serum OPG levels among the different groups according to the number of stenotic vessels and determined whether there was any correlation with aortic calcification, LV (left ventricular) mass index and serum CRP (C-reactive protein) levels. Subjects (n = 100; mean age, 57 years) who underwent coronary angiograms were enrolled. Blood pressure, body mass index, fasting blood glucose, lipid profiles and CRIP levels were measured and the LV mass indices were calculated using ECGs. Serum OPG levels were measured by ELISA. The presence of calcification in the aortic notch was checked by a chest X-ray. The subjects were divided into four groups according to the number of stenotic vessels. The mean serum OPG levels increased significantly as the number of stenotic vessels increased, and the mean serum OPG levels were higher in the group with three-vessel disease compared with the groups with no- or one-vessel disease. The mean serum CRP level was significantly higher in the group with three-vessel disease compared with the groups with no-, one- and two-vessel disease. Age and LV mass index showed significant positive correlations with serum OPG levels, although significance was lost after an adjustment for age. Serum CRP levels were positively correlated with serum OPG levels even after an adjustment for age. There were no differences in serum OPG levels according to the presence of fasting hyperglycaemia or aortic calcification. In conclusion, serum OPG level was related to the severity of stenotic coronary arteries and serum CRP levels. LV mass indices showed no significant correlation with OPG levels. The precise mechanism for the role of OPG in atherosclerosis needs to be investigated further.
引用
收藏
页码:237 / 243
页数:7
相关论文
共 33 条
  • [11] Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease
    Jono, S
    Ikari, Y
    Shioi, A
    Mori, K
    Miki, T
    Hara, K
    Nishizawa, Y
    [J]. CIRCULATION, 2002, 106 (10) : 1192 - 1194
  • [12] Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure
    Kazama, JJ
    Shigematsu, T
    Yano, K
    Tsuda, E
    Miura, M
    Iwasaki, Y
    Kawaguchi, Y
    Gejyo, F
    Kurokawa, K
    Fukagawa, M
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (03) : 525 - 532
  • [13] Minireview: The OPG/RANKL/RANK system
    Khosla, S
    [J]. ENDOCRINOLOGY, 2001, 142 (12) : 5050 - 5055
  • [14] Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease
    Kiechl, S
    Schett, G
    Wenning, G
    Redlich, K
    Oberhollenzer, M
    Mayr, A
    Santer, P
    Smolen, J
    Poewe, W
    Willeit, J
    [J]. CIRCULATION, 2004, 109 (18) : 2175 - 2180
  • [15] Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications
    Knudsen, ST
    Foss, CH
    Poulsen, PL
    Andersen, NH
    Mogensen, CE
    Rasmussen, LM
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2003, 149 (01) : 39 - 42
  • [16] OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
    Kong, YY
    Yoshida, H
    Sarosi, I
    Tan, HL
    Timms, E
    Capparelli, C
    Morony, S
    Oliveira-dos-Santos, AJ
    Van, G
    Itie, A
    Khoo, W
    Wakeham, A
    Dunstan, CR
    Lacey, DL
    Mak, TW
    Boyle, WJ
    Penninger, JM
    [J]. NATURE, 1999, 397 (6717) : 315 - 323
  • [17] KRUGER MC, 1997, PROG LIPID RES, V36, P1331
  • [18] Serum levels of osteoprotegerin increase with age in a healthy adult population
    Kudlacek, S
    Schneider, B
    Woloszczuk, W
    Pietschmann, P
    Willvonseder, R
    [J]. BONE, 2003, 32 (06) : 681 - 686
  • [19] C-reactive protein: From innocent bystander to pivotal mediator of atherosclerosis
    Labarrere, CA
    Zaloga, GP
    [J]. AMERICAN JOURNAL OF MEDICINE, 2004, 117 (07) : 499 - 507
  • [20] Osteoprotegerin is an αvβ3-induced, NF-κB-dependent survival factor for endothelial cells
    Malyankar, UM
    Scatena, M
    Suchland, KL
    Yun, TJ
    Clark, EA
    Giachelli, CM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (28) : 20959 - 20962